Galderma International S.A.S., headquartered in France, is a leading global player in the dermatology and aesthetic medicine industry. Founded in 1981, the company has established a strong presence in major operational regions, including Europe, North America, and Asia. Galderma is renowned for its innovative products and services, focusing on skin health, medical dermatology, and aesthetic solutions. Its core offerings include the popular Restylane® range of dermal fillers and the Sculptra® collagen-stimulating injectable, both of which are distinguished by their unique formulations and proven efficacy. With a commitment to advancing dermatological science, Galderma has achieved significant milestones, positioning itself as a trusted partner for healthcare professionals and patients alike. The company continues to lead the market with its dedication to research and development, ensuring it remains at the forefront of the industry.
How does Galderma International S.A.S's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Galderma International S.A.S's score of 37 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Galderma International S.A.S, headquartered in France, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Galderma Group AG, which may influence its climate commitments and reporting practices. Despite the lack of direct emissions data, Galderma International S.A.S is part of a broader corporate family that may have established climate initiatives. However, no specific reduction targets or commitments have been documented for Galderma International S.A.S, nor are there any climate pledges or SBTi (Science Based Targets initiative) targets reported. As a subsidiary, Galderma International S.A.S may align its environmental strategies with those of its parent company, Galderma Group AG, but specific details on emissions or climate commitments are not available at this time. The absence of reported data suggests that the company may still be in the process of developing its climate strategy or reporting framework.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 9,800,000 | 0,000,000 |
| Scope 2 | 4,200,000 | 000,000 |
| Scope 3 | - | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Galderma International S.A.S has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

